Jagsonpal Pharmaceuticals Limited 507789 Financial and Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Nov 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Chemical and Pharmaceutical Plants Construction in Bulgaria to 2018: Market Databook

Chemical and Pharmaceutical Plants Construction in Bulgaria to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • November 2014
  • 33 pages

Synopsis Timetric's 'Chemical and Pharmaceutical Plants Construction in Bulgaria to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: Bulgaria

Chemical and Pharmaceutical Plants Construction in Germany to 2018: Market Databook

Chemical and Pharmaceutical Plants Construction in Germany to 2018: Market Databook

  • $ 500
  • Industry report
  • by Timetric
  • November 2014
  • 33 pages

Synopsis Timetric's 'Chemical and Pharmaceutical Plants Construction in Germany to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, ...

Industries: Pharmaceutical | Countries: Germany

Agennix AG (Symbol:AGX) SWOT Analysis, Strategy, Revenues and Profits

Agennix AG (Symbol:AGX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Agennix AG SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Germany, United States

ALDA Pharmaceuticals Corp. (Symbol:APH) SWOT Analysis, Strategy, Revenues and Profits

ALDA Pharmaceuticals Corp. (Symbol:APH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. ALDA Pharmaceuticals Corp. SWOT Analysis report provides you a strategic ...

Industries: Pharmaceutical | Countries: Canada

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: United States

Ankur Drugs and Pharma Ltd. (ANKURDRUGS) - Financial and Strategic SWOT Analysis Review

Ankur Drugs and Pharma Ltd. (ANKURDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Ankur Drugs and Pharma Ltd. (Ankur Drugs) is a pharmaceutical company. The company manufactures and markets pharmaceuticals formulations to healthcare markets. It offers products through the categories such as general products, cephalosporin products and betalactum products. Ankur Drugs' products ...

Industries: Drug and Medication | Countries: India

Ambalal Sarabhai Enterprises Limited (Symbol:500009) SWOT Analysis, Strategy, Revenues and Profits

Ambalal Sarabhai Enterprises Limited (Symbol:500009) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Ambalal Sarabhai Enterprises Limited SWOT Analysis report provides ...

Industries: Drug and Medication

Ascent Pharmahealth Limited (Symbol:APH) SWOT Analysis, Strategy, Revenues and Profits

Ascent Pharmahealth Limited (Symbol:APH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Ascent Pharmahealth Limited SWOT Analysis report provides you a strategic ...

Industries: Generic Drug | Countries: Australia

Astralis, Ltd. SWOT Analysis, Strategy, Revenues and Profits

Astralis, Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.